LITTLE KNOWN FACTS ABOUT SITUS JUDI MBL77.

Not all clients with CLL need therapy. In spite of all the latest advances, the iwCLL even now recommends watchful observation for patients with asymptomatic condition.86 This suggestion is based on at the least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104